KPV vs Phosphate Buffered Saline
A side-by-side research comparison of KPV and Phosphate Buffered Saline across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | KPV | Phosphate Buffered Saline |
|---|---|---|
| Full name | Lysine-Proline-Valine Tripeptide | Phosphate Buffered Saline (PBS) |
| Category | Healing & Recovery | Healing & Recovery |
| Status | Research compound | Buffer solvent |
| Mechanism | Inhibits NF-kB signaling pathway, reduces pro-inflammatory cytokine production (TNF-α, IL-6), and modulates immune cell activation. | The phosphate buffer maintains a stable, near-physiological pH (~7.4) while the saline provides isotonic conditions, protecting peptides and proteins from pH-driven degradation during dissolution and handling. |
| Molecular weight | 342.43 Da | Buffered salt solution |
| Half-life | ~2-3 hours | N/A (solvent) |
| Bioavailability | ~60-70% oral; higher subcutaneous | N/A (diluent) |
| Typical dose | 200-500 mcg per dose | Volume to reach target concentration |
| Frequency | 1-2x daily | As needed to reconstitute |
| Route | Oral, topical, or subcutaneous | Added to peptide/protein vial |
KPV reported benefits
- Potent anti-inflammatory
- Gut inflammation reduction
- Skin condition improvement
- Immune modulation
Phosphate Buffered Saline reported benefits
- Maintains stable physiological pH
- Isotonic and gentle on peptides/proteins
- Neutral research-grade diluent
Related comparisons
Research and educational reference only. Not medical advice.